We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $37 · 5 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Calumet (CLMT) director granted 1,290 restricted stock units as equity pay - Stock Titan
Calumet (CLMT) director granted 1,290 restricted stock units as equity pay Stock Titan
Calumet (CLMT) director John G. Boss awarded 281 restricted stock units - Stock Titan
Calumet (CLMT) director John G. Boss awarded 281 restricted stock units Stock Titan
[Form 4] Calumet, Inc. /DE Insider Trading Activity - Stock Titan
[Form 4] Calumet, Inc. /DE Insider Trading Activity Stock Titan
Calumet (CLMT) director granted new restricted stock unit awards - Stock Titan
Calumet (CLMT) director granted new restricted stock unit awards Stock Titan
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 07. | After market close (AMC) | $-0.01 | — | — | $1.09B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-1.87 | — | — | $993.9M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-2.21 | — | — | $3.24B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.98 | — | — | $2.14B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 03. 30. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 13. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2026. 01. 31. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 11. 10. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 10. 23. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 08. 12. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.